Trial Profile
Safety and Efficacy of Intranasal Dexmedetomidine as a Sedative in Pediatric Dentistry: a Randomized, Double-blind Clinical Study
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Midazolam (Primary) ; Nitrous oxide (Primary)
- Indications Sedation
- Focus Adverse reactions; Therapeutic Use
- 09 Dec 2016 New trial record